how should we integrate new immunotherapies into treatment strategies for lung cancer?
Published 11 years ago • 80 plays • Length 4:17Download video MP4
Download video MP3
Similar videos
-
11:36
immunotherapy for lung cancer: currently enrolling clinical trials of combination therapies
-
42:48
immunotherapy for lung cancer
-
1:46
immunotherapy for patients with resectable nsclc & driver mutation-targeted therapies in lung cancer
-
4:09
immunotherapy combinations: is this the future for treating lung cancer?
-
3:13
immunotherapy in lung cancer: history and strategies - lcvl 2024
-
21:19
lung cancer immunotherapy q&a
-
12:04
currently enrolling clinical trials of single agent immunotherapies for patients with lung cancer
-
4:56
immunotherapy for previously treated advanced non-small cell lung cancer
-
3:45
immunotherapy for small cell lung cancer
-
2:08
in what clinical setting should immunotherapies be developed?
-
6:08
chemo /- immunotherapy for mesothelioma-leading developments & current questions in lung cancer
-
26:02
doctors discuss: immunotherapy in lung cancer
-
11:12
the future of cancer immunotherapy: combination treatments
-
3:46
immunotherapy as first-line treatment
-
1:48
preoperative or postoperative immunotherapy? - lung cancer onctalk 2022
-
1:36
q&a: does braf in non-smokers respond to immunotherapy? - targeted therapies in lung cancer 2023
-
10:59
why is immunotherapy more effective in some cancers than others? - part 1
-
35:07
the current role of immunotherapy in the treatment of patients with cancer
-
3:01
is it feasible and clearly beneficial to combine immunotherapy approaches?